Navigation Links
Reported Decline in U.S. Pneumonia Deaths May Be False: Study
Date:4/4/2012

By Mary Brophy Marcus
HealthDay Reporter

TUESDAY, April 3 (HealthDay News) -- Recent reports showing a big dip in U.S. pneumonia cases and related deaths may be the result of a glitch in the way hospitals code for pneumonia and associated illnesses, rather than a treatment breakthrough, a new study suggests.

"We had observed that over a very brief period of time, between 2003 and 2009, the number of admissions to hospitals for pneumonia was decreasing rather dramatically and, at the same time, the mortality rate for patients hospitalized for pneumonia was also decreasing rather dramatically," said study author Dr. Peter Lindenauer, director of the Center for Quality of Care Research at Baystate Medical Center in Springfield, Mass.

"We don't have a new drug that might suggest the drop, so one of the things we thought we needed to investigate were changes in diagnostic coding choices," said Lindenauer, also an associate professor of medicine at Tufts University School of Medicine in Boston.

Pneumonia, one of the nation's top killers, causes more than a million hospitalizations a year in the United States.

For the study, published April 4 in the Journal of the American Medical Association, Lindenauer and colleagues analyzed trends in hospital admissions and survival in patients with pneumonia, and in patients diagnosed with sepsis or respiratory failure, two related illnesses, combined with pneumonia. Sepsis is a life-threatening bacterial infection.

The researchers calculated how many cases were coded as a principal diagnosis of pneumonia, and how many cases were given a principal diagnosis of sepsis or respiratory failure with a secondary diagnosis code of pneumonia.

"A physician's primary responsibility is to document a clinical diagnosis, impressions, and create a patient treatment plan," said Lindenauer. He said it's ultimately the job of the hospital coders (large staffs engaged in
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Rare medical phenomenon of systemic tumor disappearance following local radiation treatment reported in a patient with metastatic melanoma
2. 19 Million New STD Infections Reported Annually, CDC Says
3. Fewer Diabetic Vision Problems Reported: CDC
4. Results of the ROTAXUS trial reported at TCT 2011
5. Results of the ADVISE trial reported at TCT 2011
6. Results of the COBRA trial reported at TCT 2011
7. Results of the PROFI study reported at TCT 2011
8. Results of the EVOLVE trial reported at TCT 2011
9. Results of the REMEDEE trial reported at TCT 2011
10. Results of the NEXT clinical trial Reported at TCT 2011
11. Results of the PEPCAD-DES trial reported at TCT 2011
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Reported Decline in U.S. Pneumonia Deaths May Be False: Study  
(Date:8/3/2015)... ... August 03, 2015 , ... The Workgroup for Electronic Data Interchange ... to create efficiencies in healthcare information exchange, announced the release of its findings from ... Human Services (HHS) Secretary, WEDI shared survey results and recommendations , ...
(Date:8/3/2015)... Angeles, California (PRWEB) , ... August 03, 2015 ... ... on the Atlanta Journal Constitution, the new Lifetime reality series, “Atlanta Plastic” ... who performs and who receives plastic surgery, with its predominantly African-American cast of ...
(Date:8/3/2015)... ... August 03, 2015 , ... According to an opinion piece published July 28 by ... to one pound of weight loss may not be accurate. While this system may work ... pound of fat varies – based both on the individual and at what point that ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... They know ... Providence St. Vincent Medical Center offers some of the best care in the ... neurosurgeon and neurointerventionalist, achieved the fastest average blood clot removal time in the country. ...
(Date:8/3/2015)... Pennsylvania (PRWEB) , ... August 03, 2015 , ... Bayer ... Yaz and Yasmin related claims in which a claimant alleged to have suffered an ... related to the birth control pills, Yaz, Yasmin and Ocella, has been ongoing for ...
Breaking Medicine News(10 mins):Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 4Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 2Health News:Article on Lifetime’s New “Atlanta Plastic” Reality Series Underlines the Diversity of Today’s Plastic Surgery Patients, Says Plastic Surgeon Dr. J 3Health News:Article Dispelling Weight Loss Myth Correctly Emphasizes the Complicated and Difficult Nature of Weight Loss, Says Dr. Michael Feiz 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Bayer Agrees To Settle Yaz Aterial Blood Clot Lawsuits 2
... reflect results of new study , , FRIDAY, Jan. 18 (HealthDay ... American women carries a risk of serious blood clots that ... control pill, the U.S. Food and Drug Administration warned ... study that discovered the increased danger, the agency said it ...
... in Vegan Diet War, WASHINGTON, Jan. 18 ... the misleading Physicians Committee,for Responsible Medicine (PCRM) for ... which sued eight restaurant chains this week,over the ... been exposed,in Newsweek and The New York Times ...
... the United States Food and,Drug Administration (FDA) has ... cholesterol lowering medication also indicated for,improving glycemic control ... in,combination with metformin, sulfonylureas, or insulin, when these ... anti-diabetic agents., The ADA estimates that 20.8 ...
... Jan. 18 175 students from,the Academy of Columbus, ... the sixth annual Give Kids A Smile! Day state ... state kick-off will be held in the Atrium at ... from,The Ohio State University College of Dentistry, legislators and ...
... aggressive disease in 2 men taking the product , , ... product described as a dietary supplement appears to have ... two men, researchers report. , "There were things on ... components in the product that were not on the ...
... Part of Available Resources-, JACKSONVILLE, Fla., Jan. ... group of returning wounded veterans are the most ... has expanded,their ever-evolving battery of programs and services ... initiative., The Warriors to Work (WtoW) program ...
Cached Medicine News:Health News:FDA Warns Clot Risk Higher in Birth Control Patch Than Pill 2Health News:FDA Warns Clot Risk Higher in Birth Control Patch Than Pill 3Health News:Phony 'Physicians Committee' Suing Restaurants is Animal-Rights Trojan Horse, says CCF 2Health News:MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS 2Health News:Statehouse Atrium to be Site for Children's Dental Access Event - Ohio Legislators to Mingle With Children and Dentists for This Free Care Event! 2Health News:Mislabled Supplement Spurred Prostate Cancer: Report 2Health News:Mislabled Supplement Spurred Prostate Cancer: Report 3Health News:Wounded Warrior Project (WWP) Expands Service Offerings for Injured Soldiers with the New 'Warriors to Work' Program 2
(Date:8/3/2015)... , Aug. 3, 2015 Par Pharmaceutical ... conference call on Friday, August 7, 2015 at 9:00 ... the second quarter ended June 30, 2015.  Par is ... to the public in its filings with the Securities ... available on its website by following the instructions at ...
(Date:8/3/2015)... , Aug. 3, 2015 OmniSeq, LLC ... Institute to the OmniSeq SM Genomic Network.  ... Cancer Institute (RPCI) and announced it was making ... a physician-driven, collaborative approach to genomic diagnostics that ... Cancer Institute is a rapidly expanding, multidisciplinary cancer ...
(Date:8/3/2015)...  Sage Analytics ( www.sageanalytics.com ), the developers of ... systems, announced its sponsorship of the California Cannabis Industry ... number of tickets are available for groups or individuals ... while enjoying an open bar, buffet dinner and hors ... Bay at sunset. With the legislative session ...
Breaking Medicine Technology:OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2
... YORK, April 9, 2008 Intra-Cellular Therapies, ... ongoing development,programs for ITI-007, the Company,s first-in-class ... and ITI-722,a low-dose formulation of ITI-007, which ... respectively. These new data demonstrate,ITI-007 has preclinical ...
... ... - Preliminary Phase I/II results to be presented in June at 2008 ... ... ), a clinical-stage biopharmaceutical company,focused on oncology, announced today that it has advanced CR011-vcMMAE, ...
Cached Medicine Technology:Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 2Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 3CuraGen Advances CR011-vcMMAE into Phase II 2CuraGen Advances CR011-vcMMAE into Phase II 3CuraGen Advances CR011-vcMMAE into Phase II 4
... HIV-1 Genotyping: The genome of ... in an infected patient, especially in response ... mutations have been shown to render the ... drugs, diminishing the effectiveness of the treatment.,The ...
EIA for Donor Screening. Synthetic peptide Enzyme Immunoassay (EIA) for the detection of antibodies to Human Immunodeficiency Virus Types 1 and/or 2,(HIV-1 and HIV-2) in human serum, plasma or ca...
... The Reveal Rapid HIV-1 Antibody Test (Reveal ... This test detects antibodies in human serum ... by the body in response to HIV ... MedMiras proprietary flow-through membrane technology, and is ...
... The OraQuick ADVANCE ... is a single-use, qualitative ... to Human Immunodeficiency Virus ... Type 2 (HIV-2) in ...
Medicine Products: